Proteostasis Therapeutics
Why Robinhood?
You can watch PTI and buy or sell other stocks, ETFs, and their options commission-free!About PTI
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
PTI Key Statistics
Stock Snapshot
As of today, Proteostasis Therapeutics(PTI) shares are valued at $1.89. The company's market cap stands at 25.59M, with a P/E ratio of -0.50.
During the trading day, Proteostasis Therapeutics(PTI) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 15.46K.
Over the past 52 weeks, Proteostasis Therapeutics(PTI) stock has traded between a high of $1.15 and a low of $0.18.
Over the past 52 weeks, Proteostasis Therapeutics(PTI) stock has traded between a high of $1.15 and a low of $0.18.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.